Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks in news: TCS, Groww, Shriram Finance, Dixon Tech, Anand Rathi Wealth
Indian markets saw a rebound on Thursday, recovering from Wednesday's sharp sell-off. TCS reported a 5% year-on-year profit growth, and Groww affirmed its direct mutual fund strategy. Shriram Finance is raising funds to reduce borrowing costs after a rating upgrade. Maruti Suzuki plans to add service points, and Dixon Tech will expand smartphone manufacturing. Premier Energies commissioned a solar module facility, and Anand Rathi Wealth saw profit rise.
Bajaj Finserv Q1 Update: Bajaj General premium up 22% YoY to ₹1,760 crore
Shares of Bajaj Finserv Ltd ended at ₹1,894.25, up by ₹39.60, or 2.14%, on the BSE.
Nifty Auto up 1% on record June sales; TVS Motor, Bajaj Auto among top bets
According to FADA, the share of electric vehicles in overall two-wheeler sales rose to 10.6 per cent, hitting the double-digit mark for the first time.
Jefferies Says It's Time To Sell BSE, Turns Bullish On BPCL, IOCL, Bajaj Finserv And TVS
Jefferies sees oil marketers, cement, and auto as the trade to make after crude's retreat.
Bajaj Auto Ltd down for fifth straight session
Bajaj Auto Ltd is quoting at Rs 10139, down 0.05% on the day as on 13:19 IST on the NSE. The stock jumped 18.35% in last one year as compared to a 6.57% slide in NIFTY and a 10.3% spurt in the Nifty Auto index.
Rajiv Bajaj to exit Board of Bajaj Finserv too
Rajiv Bajaj is moving on from his role on the board of Bajaj Finserv, a transition that follows his earlier departure from Bajaj Finance. This change comes amidst growing demands in his responsibilities at Bajaj Auto, particularly with the integration of its credit operations and the KTM acquisition initiative.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Rajiv Bajaj to step down from Bajaj Finserv board, will not seek re-election at 2026 AGM
Bajaj Finserv's non-executive director Rajiv Bajaj will exit the board due to increased responsibilities at Bajaj Auto. He will not seek re-election at the upcoming AGM. Details here.
Rajiv Bajaj to step down from Bajaj Finserv board, cites growing responsibilities at Bajaj Auto
Bajaj Finserv announces non executive director Rajiv Bajaj will step down at the July 31 AGM, citing growing responsibilities at Bajaj Auto.
Rajiv Bajaj to step down from Bajaj Finserv board, cites growing responsibilities at Bajaj Auto
Rajiv Bajaj will step down as a non-executive director of Bajaj Finserv, not seeking re-election at the July 31, 2026 AGM. Citing increased responsibilities at Bajaj Auto, including oversight of new businesses and the KTM acquisition, he aims to reduce external commitments. This follows his recent departure from the Bajaj Finance board.